Report Categories
View AllRecent Articles
View All
PYXS Pyxis Oncology beats Q4 2025 loss estimates but shares shed 235 percent amid weak investor reaction
COSM Cosmos Health shares slide as Q4 earnings miss widens to 660 percent shocking investors with steep loss
GSD Goldman quarterly earnings results remain undisclosed management to outline key strategic priorities in upcoming investor call
How Caesars CZR balances short term and long term focus Caesars posts 1017 EPS miss far below estimates